Log in to save to my catalogue

Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada

Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1e83463a1e594b5784345b5b95c88a12

Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada

About this item

Full title

Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada

Publisher

England: BioMed Central Ltd

Journal title

BMC public health, 2021-05, Vol.21 (1), p.843-843, Article 843

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

The opioid overdose epidemic in Canada and the United States has become a public health crisis - with exponential increases in opioid-related morbidity and mortality. Recently, there has been an increasing body of evidence focusing on the opioid-sparing effects of medical cannabis use (reduction of opioid use and reliance), and medical cannabis as...

Alternative Titles

Full title

Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1e83463a1e594b5784345b5b95c88a12

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1e83463a1e594b5784345b5b95c88a12

Other Identifiers

ISSN

1471-2458

E-ISSN

1471-2458

DOI

10.1186/s12889-021-10867-w

How to access this item